Similar outcome was also observed in patients treated with four vs. eight weeks of asparagine depletion in the Children’s Oncology Group AALL0331 trial in low risk ALL of which 62.7% was ETV6::RUNX1 positive [34]. This evidence concerns the gene RUNX1 and acute lymphoblastic leukemia.